Alicia Gresham stands on a staircase in a historic building of Pennsylvania Hospital

Alicia Gresham of Mount Sinai named chief executive officer of Pennsylvania Hospital

Alicia Gresham of Mount Sinai Health System has been named chief executive officer of Pennsylvania Hospital.

  • Kelsey Geesler
  • October 26, 2023

Alicia Gresham has been named chief executive officer of Pennsylvania Hospital, effective January 2, 2024. Gresham currently serves as senior vice president and COO of Network Operations at Mount Sinai Health System in New York and has nearly three decades of executive leadership experience in health care.

During her time at Mount Sinai, Gresham led the expansion of the health system’s ambulatory practices across the five boroughs of New York, Westchester, Long Island, New Jersey, and Florida. Her work has been instrumental in increasing practice revenues, improving patient access, and integrating practices into a unified electronic health record. She was also a key player in establishing strong partnerships with affiliate hospitals and physician groups across the region.

Gresham returns to Penn Medicine

Gresham’s appointment at Pennsylvania Hospital marks a return to Penn Medicine, where she previously led special projects for the department of Medicine and later served as the director of Access and Operations for the Scheie Eye Institute. After her posts at Penn Medicine, she served as senior director of Specialty Care and Primary Care for Children’s Hospital of Philadelphia (CHOP) where she led the development and execution of expanding CHOP’s network practices in the greater Philadelphia region. At Pennsylvania Hospital, she succeeds Theresa Larivee, who was named Chief Business Officer for the University of Pennsylvania Health System (UPHS) in January 2023, following eight years as PAH’S CEO.

“Alicia has deep strategic, operations, and financial acumen, which she has leveraged to build well-integrated networks for large academic health systems,” said Michele Volpe, UPHS Chief Operating Officer. “I am thrilled to welcome her back to Penn Medicine, where she will build upon Pennsylvania Hospital’s plans for growth with a continued focus on the needs of the community we serve and our exceptionally talented workforce.”

Pennsylvania Hospital is the nation’s first hospital, founded in 1751 by Benjamin Franklin and Dr. Thomas Bond. Over its 270 years in operation, the hospital has earned national recognition for programs such as orthopaedics, neurosurgery, obstetrics and high-risk maternal and fetal services, neonatology and behavioral health. The campus also includes specialty treatment centers such as the Center for Transfusion-Free Medicine, and the Penn Gamma Knife Center. Home to 525 licensed inpatient beds, Pennsylvania Hospital saw 303,368 outpatient visits, 45,352 emergency department visits, and 5,537 births in fiscal year 2022.

“As an institution that has played a major role in the story of American medicine since even before the nation’s founding, Pennsylvania Hospital in built on the values of community, tradition, and innovation,” said UPHS CEO Kevin B. Mahoney. “Alicia’s experience both within Penn Medicine and at other large academic health systems places her in the unique position to not only support Penn Medicine’s strengths and values, but also to bring fresh ideas to continue Pennsylvania Hospital’s longstanding evolution and continuous pursuit of excellence.”

Gresham holds a Master of Business Administration and a Master of Science in Healthcare Finance from the Fox School of Business at Temple University and a Bachelor of Science in Business Management from the University of Tennessee-Knoxville.

Daniel Wilson, MBA, RN, COO of Pennsylvania Hospital, will continue to serve as acting CEO during the transition period before Gresham begins her new role.

Media contact

Kelsey Geesler
C: 215-300-1194
Kelsey.Geesler@pennmedicine.upenn.edu

For Media Queries & Requests (24/7): 215-662-2560

Follow us

Related articles

Subscribe

Subscribe to Penn Medicine newsletters and publications for the latest developments.